Menu Search
Equities

Beijing Wantai Biological Pharmacy Enterprise Co Ltd

603392:SHH

Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)72.72
  • Today's Change-0.45 / -0.62%
  • Shares traded4.22m
  • 1 Year change+49.78%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy0
Outperform0
Hold1
Sell1
Strong Sell0

Share price forecast in CNY

The 2 analysts offering 12 month price targets for Beijing Wantai Biolog Pha Ent Co Ltd have a median target of 61.40, with a high estimate of 74.30 and a low estimate of 48.50. The median estimate represents a -15.57% decrease from the last price of 72.72.
High2.2%74.30
Med-15.6%61.40
Low-33.3%48.50

Dividends in CNY

In 2023, Beijing Wantai Biological Pharmacy Enterprise Co Ltd reported a dividend of 0.32 CNY, which represents a 55.20% decrease from last year. The 2 analysts covering the company expect dividends of 0.05 CNY for the upcoming fiscal year, a decrease of 85.31%.
Div growth (TTM)-55.20%
More ▼

Earnings history & estimates in CNY

On Oct 24, 2024, Beijing Wantai Biolog Pha Ent Co Ltd reported 3rd quarter 2024 earnings of 0.005 per share.
The next earnings announcement is expected on Feb 24, 2025.
Average growth rate-42.73%
Beijing Wantai Biolog Pha Ent Co Ltd reported annual 2023 earnings of 0.99 per share on Mar 28, 2024.
Average growth rate+81.70%
More ▼

Revenue history & estimates in CNY

Beijing Wantai Biolog Pha Ent Co Ltd had 3rd quarter 2024 revenues of 582.07m. This missed the 695.82m estimate of the one analyst following the company. This was 79.84% below the prior year's 3rd quarter results.
Average growth rate-4.36%
Beijing Wantai Biolog Pha Ent Co Ltd had revenues for the full year 2023 of 5.51bn. This was 50.73% below the prior year's results.
Average growth rate+62.68%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.